About this website
This website contains information relating to Mediclinic Group Limited, a company registered in the United Kingdom.
Mediclinic Group historically operated as an international healthcare group comprising Hirslanden in Switzerland, Mediclinic Southern Africa in South Africa and Namibia and Mediclinic Middle East in the United Arab Emirates, together with a minority investment in Spire Healthcare Group plc in the United Kingdom.
On 1 July 2026, a restructuring of the shareholders’ interests in the former Mediclinic Group was completed. Under the transaction:
- Mediclinic Southern Africa became wholly owned by a subsidiary of Remgro Limited.
- Hirslanden became wholly owned by Investment Holding Limited S.à r.l., a subsidiary of MSC Mediterranean Shipping Company Holding SA.
- Mediclinic Middle East remains jointly and equally owned by Remgro and Investment Holding Limited.
- The investment in Spire Healthcare Group plc remains jointly and equally owned by Remgro and Investment Holding Limited.
As a result of the transaction, Hirslanden, Mediclinic Southern Africa and Mediclinic Middle East no longer operate as divisions of Mediclinic Group.
For information about the independent healthcare businesses, please visit their respective websites:
The restructuring does not change the businesses’ unwavering commitment to enhancing the quality of life for every patient in its care. Each business remains focused on delivering specialist-orientated, multi-disciplinary healthcare services across the care continuum, supported by a long-standing commitment to clinical excellence, quality and patient safety.